161 related articles for article (PubMed ID: 26776187)
1. REPURPOSING GERMLINE EXOMES OF THE CANCER GENOME ATLAS DEMANDS A CAUTIOUS APPROACH AND SAMPLE-SPECIFIC VARIANT FILTERING.
Koire A; Katsonis P; Lichtarge O
Pac Symp Biocomput; 2016; 21():207-18. PubMed ID: 26776187
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer analysis reveals technical artifacts in TCGA germline variant calls.
Buckley AR; Standish KA; Bhutani K; Ideker T; Lasken RS; Carter H; Harismendy O; Schork NJ
BMC Genomics; 2017 Jun; 18(1):458. PubMed ID: 28606096
[TBL] [Abstract][Full Text] [Related]
3. The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.
Garofalo A; Sholl L; Reardon B; Taylor-Weiner A; Amin-Mansour A; Miao D; Liu D; Oliver N; MacConaill L; Ducar M; Rojas-Rudilla V; Giannakis M; Ghazani A; Gray S; Janne P; Garber J; Joffe S; Lindeman N; Wagle N; Garraway LA; Van Allen EM
Genome Med; 2016 Jul; 8(1):79. PubMed ID: 27460824
[TBL] [Abstract][Full Text] [Related]
4. Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
Rasnic R; Brandes N; Zuk O; Linial M
BMC Cancer; 2019 Aug; 19(1):783. PubMed ID: 31391007
[TBL] [Abstract][Full Text] [Related]
5. A method to reduce ancestry related germline false positives in tumor only somatic variant calling.
Halperin RF; Carpten JD; Manojlovic Z; Aldrich J; Keats J; Byron S; Liang WS; Russell M; Enriquez D; Claasen A; Cherni I; Awuah B; Oppong J; Wicha MS; Newman LA; Jaigge E; Kim S; Craig DW
BMC Med Genomics; 2017 Oct; 10(1):61. PubMed ID: 29052513
[TBL] [Abstract][Full Text] [Related]
6. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.
Koboldt DC; Zhang Q; Larson DE; Shen D; McLellan MD; Lin L; Miller CA; Mardis ER; Ding L; Wilson RK
Genome Res; 2012 Mar; 22(3):568-76. PubMed ID: 22300766
[TBL] [Abstract][Full Text] [Related]
7. Personalized genomic analyses for cancer mutation discovery and interpretation.
Jones S; Anagnostou V; Lytle K; Parpart-Li S; Nesselbush M; Riley DR; Shukla M; Chesnick B; Kadan M; Papp E; Galens KG; Murphy D; Zhang T; Kann L; Sausen M; Angiuoli SV; Diaz LA; Velculescu VE
Sci Transl Med; 2015 Apr; 7(283):283ra53. PubMed ID: 25877891
[TBL] [Abstract][Full Text] [Related]
8. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
[TBL] [Abstract][Full Text] [Related]
9. Intersect-then-combine approach: improving the performance of somatic variant calling in whole exome sequencing data using multiple aligners and callers.
Callari M; Sammut SJ; De Mattos-Arruda L; Bruna A; Rueda OM; Chin SF; Caldas C
Genome Med; 2017 Apr; 9(1):35. PubMed ID: 28420412
[TBL] [Abstract][Full Text] [Related]
10. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples.
Bailey MH; Meyerson WU; Dursi LJ; Wang LB; Dong G; Liang WW; Weerasinghe A; Li S; Li Y; Kelso S; ; ; Saksena G; Ellrott K; Wendl MC; Wheeler DA; Getz G; Simpson JT; Gerstein MB; Ding L;
Nat Commun; 2020 Sep; 11(1):4748. PubMed ID: 32958763
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive benchmarking of SNV callers for highly admixed tumor data.
Bohnert R; Vivas S; Jansen G
PLoS One; 2017; 12(10):e0186175. PubMed ID: 29020110
[TBL] [Abstract][Full Text] [Related]
12. Detailed simulation of cancer exome sequencing data reveals differences and common limitations of variant callers.
Hofmann AL; Behr J; Singer J; Kuipers J; Beisel C; Schraml P; Moch H; Beerenwinkel N
BMC Bioinformatics; 2017 Jan; 18(1):8. PubMed ID: 28049408
[TBL] [Abstract][Full Text] [Related]
13. Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing.
Hollegaard MV; Grauholm J; Nielsen R; Grove J; Mandrup S; Hougaard DM
Mol Genet Metab; 2013; 110(1-2):65-72. PubMed ID: 23830478
[TBL] [Abstract][Full Text] [Related]
14. BAYSIC: a Bayesian method for combining sets of genome variants with improved specificity and sensitivity.
Cantarel BL; Weaver D; McNeill N; Zhang J; Mackey AJ; Reese J
BMC Bioinformatics; 2014 Apr; 15():104. PubMed ID: 24725768
[TBL] [Abstract][Full Text] [Related]
15. A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine.
Van Allen EM; Robinson D; Morrissey C; Pritchard C; Imamovic A; Carter S; Rosenberg M; McKenna A; Wu YM; Cao X; Chinnaiyan A; Garraway L; Nelson PS
Oncotarget; 2016 Aug; 7(33):52888-52899. PubMed ID: 27167109
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of Clinical Whole-Exome and Whole-Genome Sequencing for Detection of Germline Variants in Inherited Disease.
Hegde M; Santani A; Mao R; Ferreira-Gonzalez A; Weck KE; Voelkerding KV
Arch Pathol Lab Med; 2017 Jun; 141(6):798-805. PubMed ID: 28362156
[TBL] [Abstract][Full Text] [Related]
17. Germline contamination and leakage in whole genome somatic single nucleotide variant detection.
Sendorek DH; Caloian C; Ellrott K; Bare JC; Yamaguchi TN; Ewing AD; Houlahan KE; Norman TC; Margolin AA; Stuart JM; Boutros PC
BMC Bioinformatics; 2018 Jan; 19(1):28. PubMed ID: 29385983
[TBL] [Abstract][Full Text] [Related]
18. GrabBlur--a framework to facilitate the secure exchange of whole-exome and -genome SNV data using VCF files.
Stade B; Seelow D; Thomsen I; Krawczak M; Franke A
BMC Genomics; 2014; 15 Suppl 4(Suppl 4):S8. PubMed ID: 25055742
[TBL] [Abstract][Full Text] [Related]
19. Lower Exome Sequencing Coverage of Ancestrally African Patients in The Cancer Genome Atlas.
Wickland DP; Sherman ME; Radisky DC; Mansfield AS; Asmann YW
J Natl Cancer Inst; 2022 Aug; 114(8):1192-1199. PubMed ID: 35299252
[TBL] [Abstract][Full Text] [Related]
20. Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas.
Buckley AR; Ideker T; Carter H; Harismendy O; Schork NJ
Genome Med; 2018 Sep; 10(1):69. PubMed ID: 30217226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
